Shawn Tomasello, Chief Commercial Officer at Kite Pharma, Inc. (KITE), sold 9,802 shares at $50.86 ($499K) on 2016-12-20, disclosed to the SEC on 2016-12-22.
Open-market sale of $499k KITE by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.86 | 4,901 | $249K | 50.0% |
| 2 | $50.86 | 4,901 | $249K | 50.0% |
| Total | $50.86 avg | 9,802 | $499K | 100% |
| Filing → |
| DPLO | SELL | 2019-10-04 | $4K | — | Filing → |
| DPLO | SELL | 2019-06-05 | $6K | — | Filing → |
| DPLO | SELL | 2018-06-05 | $41K | — | Filing → |